CATALYST PHARMACEUTICALS, INC. (CPRX) › Capital ExpendituresCATALYST PHARMACEUTICALS, INC. (CPRX) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2009: $2.3K2010: $2.9K2011: $3.6K2012: $52.4K2013: $9.4K2014: $57.3K2015: $23.5K2016: $96.1K2018: $92.0K2019: $19.0K2020: $11.0K2021: $1.02M2022: $29.0K2023: $231.0K2024: $556.0K2025: $58.0K$58.0K2009Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$58.0K-89.6%2024$556.0K+140.7%2023$231.0K+696.6%2022$29.0K-97.2%2021$1.02M+9181.8%2020$11.0K-42.1%2019$19.0K-79.4%2018$92.0K—2016$96.1K+309.4%2015$23.5K-59.1%2014$57.3K+507.8%2013$9.4K-82.0%2012$52.4K+1347.0%2011$3.6K+26.3%2010$2.9K+24.8%2009$2.3K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share